title: Sustained left ventricular outflow tract ventricular tachycardia following transcatheter aortic valve replacement.
authors.affiliation: Division of Cardiology, Department of Medicine, Long Beach Veterans Affairs Medical Center, 5901 East 7th Street, 111C, Long Beach, CA 90822, California.|Division of Cardiology, Department of Medicine, University of California, Irvine Medical Center, 333 City Blvd. West Suite 400 Orange, CA 92868-4080, California.
authors.forename: Arnold H
authors.initials: AH
authors.lastname: Seto
authors.affiliation: Division of Cardiology, Department of Medicine, University of California, Irvine Medical Center, 333 City Blvd. West Suite 400 Orange, CA 92868-4080, California.
authors.forename: Nicholas J
authors.initials: NJ
authors.lastname: Abbott
authors.affiliation: Department of Medicine, The Heart Institute, Cedars-Sinai Medical Center, Advanced Health Science Pavillion., A3600, 127 S. San Vincente, Los Angeles, CA 90048, California.
authors.forename: Rajendra R
authors.initials: RR
authors.lastname: Makkar
authors.affiliation: Pacific Rim Electrophysiology Research Institute, White Memorial Medical Center, 1700 Cesar Chavez Blvd., Suite 2700, Los Angeles, CA 90033, California.
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Salazar
mesh_terms: D000369:Aged, 80 and over; D000638:Amiodarone / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D001024:Aortic Valve Stenosis / Q000601:surgery*; D004562:Electrocardiography; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000209:etiology; D017180:Tachycardia, Ventricular / Q000209:etiology*; D065467:Transcatheter Aortic Valve Replacement / Q000009:adverse effects*
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone